| 68Ga-FAPI-04 PET/CT in selected breast cancer patients with low FDG affinity: a head-to-head comparative study G Alçın, E Arslan, T Aksoy, M Cin, ÖE Fenercioğlu, E Beyhan, N Ergül, ... Clinical Nuclear Medicine 48 (9), e420-e430, 2023 | 20 | 2023 |
| 18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT Findings of Bilateral Knee Osteoarthritis in a Patient With Uveal Malignant Melanoma. Ö Erol Fenercioğlu, E Beyhan, N Ergül, E Arslan, TF Çermik Clinical Nuclear Medicine, 2021 | 20 | 2021 |
| 68Ga-FAPI-04 PET/CT findings in patients with liver cirrhosis G Tatar, E Beyhan, ÖE Fenercioğlu, İ Sevindi, N Ergül, TF Çermik Molecular Imaging and Radionuclide Therapy 32 (2), 146, 2023 | 8 | 2023 |
| Diagnostic impact of 18F-FDG PET/CT imaging on the detection of immune-related adverse events in patients treated with immunotherapy G Tatar, G Alçin, N Sengul Samanci, Ö Erol Fenercioglu, E Beyhan, ... Clinical and Translational Oncology 24 (10), 1903-1913, 2022 | 8 | 2022 |
| The roles of 68Ga-PSMA PET/CT and 18F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with … E Arslan, N Ergül, E Beyhan, ÖE Fenercioglu, R Sahin, M Cin, SB Havare, ... Nuclear Medicine Communications 44 (4), 284-290, 2023 | 6 | 2023 |
| Findings of I-131 SPECT/CT, 18F-FDG, and 68Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma G Tatar, G Alçın, ÖE Fenercioğlu, R Şahin, TF Çermik Molecular Imaging and Radionuclide Therapy 32 (1), 57, 2023 | 5 | 2023 |
| Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma G Tatar, E Beyhan, ÖE Fenercioğlu, E Arslan, TF Çermik Clinical Nuclear Medicine 47 (9), e596-e599, 2022 | 5 | 2022 |
| Contribution of 18F-FDG PET/CT imaging in the diagnosis and management of HIV-positive patients G Tatar, TF Çermik, G Alçın, Ö Erol Fenercioğlu, A İnci, E Beyhan, N Ergül Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2021 | 5 | 2021 |
| Role of 68Ga-FAPI PET/CT in Screening Malignancy of Familial Adenomatous Polyposis. Ö Erol Fenercioğlu, E Yarikkaya, E Beyhan, TF Çermik, N Ergül Clinical Nuclear Medicine, 2022 | 4* | 2022 |
| Intense 68Ga-PSMA Uptake in Neurofibroma Mimicking Cutaneous Metastases in a Patient With Prostate Cancer. Ö Erol Fenercioğlu, E Beyhan, C Leblebici, E Arslan, TF Çermik Clinical Nuclear Medicine, 2022 | 4 | 2022 |
| Detection of Cauda Equine Syndrome With 18F-FDG PET/CT and Leptomeningeal Metastasis by 68Ga-DOTATATE in the Same Patient With Large Cell Neuroendocrine Carcinoma of Lung E Arslan, Ö Erol, E Beyhan, R Sahin, TF Çermik Clinical Nuclear Medicine 46 (6), 488-490, 2021 | 4 | 2021 |
| The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions Ö Erol Fenercioğlu, E Beyhan, R Şahin, MC Baloğlu, E Arslan, TF Çermik, ... Nuclear Medicine Communications, 10.1097, 2023 | 3* | 2023 |
| The Contribution of 68Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer E Beyhan, TF Çermik, ÖE Fenercioğlu, R Şahin, G Alçin, T Aksoy, ... Clinical Nuclear Medicine, 10.1097, 2022 | 3 | 2022 |
| Chronic Gastritis Mimicking Malignancy on 68Ga-FAPI-04 PET/CT E Beyhan, ÖE Fenercioğlu, E Yarikkaya, TF Çermik, N Ergül Clinical Nuclear Medicine, 10.1097, 2022 | 3 | 2022 |
| Role of 18F-FDG PET/CT in the assessment of therapy response and clinical outcome in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors or immunotherapy G Tatar, G Alçin, NŞ Samanci, Ö Erol Fenercioglu, E Beyhan, TF Çermik Nuclear Medicine Communications, MNM. 0000000000001553, 2022 | 3 | 2022 |
| Solitary Vulvar Involvement of Ovarian Non-Hodgkin Lymphoma Mimicking Bartholin's Abscess on 18F-FDG PET/CT. E Beyhan, N Ergül, S Bektaş, Ö Erol, TF Çermik Clinical Nuclear Medicine 46 (3), 255-257, 2021 | 3 | 2021 |
| Contribution of 68Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging: Complementary Role in PSMA-Negative Cases N Ergül, TF Çermik, G Alçın, E Arslan, ÖE Fenercioğlu, E Beyhan, R Şahin, ... Clinical Nuclear Medicine, 10.1097, 2022 | 2 | 2022 |
| Dual 177Lu–Prostate-Specific Membrane Antigen and 177Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation E Beyhan, ÖE Fenercioğlu, R Şahin, TF Çermik, N Ergül Clinical Nuclear Medicine, 10.1097, 2022 | 2 | 2022 |
| Vas Deferens and Inguinal Canal Metastasis of Prostate Cancer Revealed by 68Ga-Prostate-Specific Membrane Antigen PET/CT. Ö Erol Fenercioğlu, G Alçin, E Arslan, TF Çermik, N Ergül Clinical Nuclear Medicine, 2022 | 2 | 2022 |
| Contribution of 68 Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging N Ergul, TF Cermik, G Alcin, E Arslan, O Erol Fenercioglu, E Beyhan, ... CLINICAL NUCLEAR MEDICINE 49 (3), E105-E110, 2024 | 1 | 2024 |
